Cargando…

Adult H3K27M-mutant diffuse midline glioma with gliomatosis cerebri growth pattern: Case report and review of the literature

INTRODUCTION: H3K27M-mutant diffuse midline glioma is a recently classified unique entity predominantly affecting pediatric patients and rarely adults. The clinicopathologic features in adults remain poorly characterized. PRESENTATION OF CASE: A 36-year-old man presented with subacute progressive co...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yekula, Anudeep, Gupta, Mihir, Coley, Nicholas, U, Hoi Sang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7058855/ https://www.ncbi.nlm.nih.gov/pubmed/32145563 http://dx.doi.org/10.1016/j.ijscr.2020.02.046

Ejemplares similares

Gliomatosis cerebri mimicking diffuse demyelinating disease: Case Report
por: Mingomataj, Erli, et al.
Publicado: (2020)

Impact of adjuvant chemotherapy for gliomatosis cerebri
por: Kong, Doo-Sik, et al.
Publicado: (2010)

Gliomatosis Cerebri: Current Understanding and Controversies
por: Ranjan, Surabhi, et al.
Publicado: (2017)

Gliomatosis Cerebri in the Brain of a Cat
por: Shrader, Stephanie, et al.
Publicado: (2016)

Pediatric gliomatosis cerebri mimicking tubercular encephalitis
por: Singhal, Namit, et al.
Publicado: (2015)

Procarbazine, CCNU, and Vincristine Chemotherapy in Gliomatosis Cerebri
por: Lee, Hyun Gon, et al.
Publicado: (2014)

Bevacizumab for Patients with Recurrent Gliomas Presenting with a Gliomatosis Cerebri Growth Pattern
por: Burger, Michael C., et al.
Publicado: (2017)

NI-20 IS GLIOMATOSIS CEREBRI DIAGNOSED AS GRADEII IN NEUROIMAGING A POTENTIALLY GRADEII GLIOMA?
por: Owashi, Etsuko, et al.
Publicado: (2019)

Gliomatosis cerebri type II: two case reports
por: D’Urso, Pietro Ivo, et al.
Publicado: (2009)

A rare case of gliomatosis cerebri presenting as dementia
por: Gutch, Manish, et al.
Publicado: (2012)

Subcutaneous tumor seeding after biopsy in gliomatosis cerebri
por: Buis, Dennis R., et al.
Publicado: (2011)

Gliomatosis cerebri: Case series of six cases with review of literature
por: Yerramneni, Vamsi Krishna, et al.
Publicado: (2015)

Gliomatosis cerebri in a 10-year-old male patient
por: Strapasson, Atahualpa, et al.
Publicado: (2017)

Gliomatosis Cerebri: A Unique Presentation with Accompanying Clinical Nuance
por: Ordookhanian, Christ, et al.
Publicado: (2019)

Gliomatosis cerebri with blindness: A case report with literature review
por: Jahanshahi, Amirreza, et al.
Publicado: (2023)

Multimodal neuroimaging of gliomatosis cerebri: a case series of four patients
por: Bonomi, Robin, et al.
Publicado: (2020)

Leber’s hereditary optic neuropathy with diffuse white matter changes mimicking gliomatosis cerebri: illustrative case
por: Saruta, Wakiko, et al.
Publicado: (2021)

Absence of MGMT promoter methylation in diffuse midline glioma, H3 K27M-mutant
por: Banan, Rouzbeh, et al.
Publicado: (2017)

MRI comparative study of diffuse midline glioma, H3 K27-altered and glioma in the midline without H3 K27-altered
por: Zhao, Ji-ping, et al.
Publicado: (2022)

HGG-09. GLIOMATOSIS CEREBRI IN CHILDREN: A POOR PROGNOSTIC, HIGHLY INFILTRATIVE PHENOTYPE OF DIFFUSE PEDIATRIC HIGH-GRADE GLIOMAS WITH DISTINCT MOLECULAR FEATURES
por: Nussbaumer, Gunther, et al.
Publicado: (2023)

NI-05 CLINICOPATHOLOGICAL ANALYSIS AND METHIONINE PET ANALYSIS IN PATIENTS WITH GLIOMATOSIS CEREBRI
por: Yano, Hirohito, et al.
Publicado: (2019)

BT-05 A CASE OF GLIOMATOSIS CEREBRI WITH TOTAL SPINAL CORD EXTENSION
por: Chiba, Yasuyoshi, et al.
Publicado: (2019)

MGMT Expression Contributes to Temozolomide Resistance in H3K27M-Mutant Diffuse Midline Gliomas
por: Abe, Hideaki, et al.
Publicado: (2020)

Exploiting Gangliosides for the Therapy of Ewing’s Sarcoma and H3K27M-Mutant Diffuse Midline Glioma
por: Wingerter, Arthur, et al.
Publicado: (2021)

A validated prognostic nomogram for patients with H3 K27M-mutant diffuse midline glioma
por: Peng, Youheng, et al.
Publicado: (2023)

Clinical, radiologic, and genetic characteristics of histone H3 K27M-mutant diffuse midline gliomas in adults
por: Schulte, Jessica D, et al.
Publicado: (2020)

NI-19 A case of Leber’s hereditary optic neuropathy with diffuse white matter changes mimicking gliomatosis cerebri
por: Saruta, Wakiko, et al.
Publicado: (2021)

New Developments in the Pathogenesis, Therapeutic Targeting, and Treatment of H3K27M-Mutant Diffuse Midline Glioma
por: Argersinger, Davis P., et al.
Publicado: (2021)

A rare case of adult diffuse midline glioma with H3 K27M mutant in the prepontine cistern
por: Chen, Xueling, et al.
Publicado: (2021)

STAT3 as a biologically relevant target in H3K27M-mutant diffuse midline glioma
por: Anderson, Jacob B., et al.
Publicado: (2023)

Differences in survival prognosticators between children and adults with H3K27M‐mutant diffuse midline glioma
por: Gong, Xuan, et al.
Publicado: (2023)

A rare case of gliomatosis cerebri lurking beneath the shadows of a stroke mimic
por: Prasad, Apoorv, et al.
Publicado: (2021)

Diffuse midline gliomas, H3 K27M-mutant are associated with less peritumoral edema and contrast enhancement in comparison to glioblastomas, H3 K27M-wildtype of midline structures
por: Banan, Rouzbeh, et al.
Publicado: (2021)

HGG-50. TWO CASES OF H3 K27M-MUTANT DIFFUSE MIDLINE GLIOMA OF CERVICAL SPINAL CORD
por: Kuroha, Masae, et al.
Publicado: (2020)

Magnetic Resonance Imaging Characteristics of Molecular Subgroups in Pediatric H3 K27M Mutant Diffuse Midline Glioma
por: Hohm, Annika, et al.
Publicado: (2021)

HGG-03. THE GLYCOSPHINGOLIPIDS METABOLISM IS A NOVEL TARGET IN H3K27M-MUTANT DIFFUSE MIDLINE GLIOMA
por: Paret, Claudia, et al.
Publicado: (2021)

STAT3 is a biologically relevant therapeutic target in H3K27M-mutant diffuse midline glioma
por: Zhang, Liang, et al.
Publicado: (2022)

Glucosylceramide Synthase Inhibitors Induce Ceramide Accumulation and Sensitize H3K27 Mutant Diffuse Midline Glioma to Irradiation
por: El Malki, Khalifa, et al.
Publicado: (2023)

Adaptive rewiring of purine metabolism promotes treatment resistance in H3K27M-mutant diffuse midline glioma
por: Peterson, Erik R., et al.
Publicado: (2023)

MGMT Expression Contributes to Temozolomide Resistance in H3K27M-Mutant Diffuse Midline Gliomas and MGMT Silencing to Temozolomide Sensitivity in IDH-Mutant Gliomas
por: ABE, Hideaki, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_11u385u6nhdemb870aen2plsat